D-Wave Quantum reported Q1 2026 results on May 12 into a stock that had surged 57% over the prior month — and the market responded with a 7% single-day pullback. That tension, between a rapidly re-rated stock and a still-unprofitable quantum computing business, is the defining setup heading into the June 1 Q2 event.
The short picture is one of gradual retreat, not capitulation. Short Interest % of Free Float has eased from a recent high near 17.5% in mid-April to around 14.6% now — roughly a three-point drop as shorts covered into the price rally. That said, at 15.1% of the float (approximately 52.5 million shares), the short base remains substantial. What's notable is where it went: from April 17 to April 24, SI dropped nearly three full percentage points in a single week as the stock climbed sharply. Since then the unwinding has slowed materially, with SI holding broadly flat through the past two weeks near current levels. The ORTEX short score sits at 67.3 — elevated, reflecting a market where bearish positioning remains a live part of the story. Borrow is easy and cheap at 0.86% cost to borrow, up 16% on the week but still near the low end of the 30-day range. Availability is running at roughly 31%, tighter than mid-April but not in distress territory. With availability this tight, adding to short positions requires meaningful conviction — there isn't a wide-open lending pool to tap. The 52-week utilization peak hit 100%, a level that has not been revisited since the April squeeze.
Options positioning has shifted noticeably more cautious into and immediately after the earnings print. The put/call ratio moved to 0.727 — nearly two standard deviations above its 20-day average of 0.682 — and is running close to the upper end of its range for the year. That's not an extreme reading on an absolute basis, but the direction of travel is clear: options market participants turned more defensive around the Q1 release, and that skew has not yet unwound.
The Street maintained conviction on the name even as it trimmed targets post-earnings. Five active analyst ratings are visible from the past two weeks, all positive — Canaccord Genuity, Rosenblatt, Cantor Fitzgerald, Mizuho, and Needham all hold Buy or Outperform ratings. The only movement was target reductions: Canaccord cut to $41 from $43, and Mizuho trimmed to $29 from $31. The consensus mean price target remains $35.17 against a $22.35 close, implying roughly 57% upside to the average target. That's a wide gap, and it reflects the fundamental debate: bulls point to the $10M QCaaS agreement with a Fortune 100 customer and the $20M system sale to Florida Atlantic University as proof of commercial traction, plus the Quantum Circuits acquisition as a platform-diversification play. Bears counter with persistently negative EBITDA (the EV/EBITDA multiple is a deeply negative -55.6x), a pre-profitability balance sheet that raises dilution risk, and genuine uncertainty about the timeline for quantum computing to deliver at scale. The P/B multiple of 8.7x has expanded by over 3 points in the past month alone — investors have been paying up, and the question after the post-earnings dip is whether that expansion has legs.
Insider activity leans cautious without being alarming. On April 13, CEO Alan Baratz sold 33,778 shares at $14.25 — the stock has since run significantly higher — alongside parallel sales by the CFO and Chief Legal Officer on the same date. The April 20 sale by an EVP at $21.35 followed the rally. None of these are large in absolute dollar terms, and the 90-day net figure is a modest positive in share count terms as some offsetting acquisitions exist, but the directional signal — C-suite selling into strength across multiple months — is worth noting. No buying has appeared in recent filings.
Institutional ownership is anchored by the largest passive managers: Vanguard added 714K shares (now 9.96% of shares), BlackRock added nearly 2M shares (7.6%), and State Street added 386K. These are passive accumulation flows that likely reflect index-related rebalancing as the market cap expanded, not active conviction bets. The 194 institutional holders on record provide a reasonable ownership base, but the passive-heavy composition means there is no high-profile active manager visibly stepping in as a swing factor.
The next scheduled event is the Q2 2026 earnings call on June 1. The one prior earnings data point available shows a 5.3% single-day decline on May 7 — and Tuesday's 7% drop following the Q1 release confirms a pattern of post-earnings selling even when results are not catastrophic. That combination — a stock up 57% in a month, shorts who have already partly covered, analysts bullish but trimming targets, and a market that has twice now sold the earnings event — is what defines the setup heading into June.
See the live data behind this article on ORTEX.
Open QBTS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
